Manhattan Labs Announces Strategic Alliance with Combimatrix

Posted on: 8-13-2013

CMandML

 

On August 13th, 2013, Manhattan Labs announced its strategic partnership with CombiMatrix to expand the depth of service offerings in the women's health market. This microarray testing is the latest in miscarriage management and allows OB/GYN physicians and clinicians to better determine if there is a genetic cause for a miscarriage or other related events.

 

To read the full press release please click on the file below.

Manhattan Labs Announces Strategic Alliance with CombiMatrix

Topics Mentioned in this Article

Ask Us a Question

  • Please read our Notice of Privacy Practices before sending any personal information over the internet.

  • This field is for validation purposes and should be left unchanged.